GLOBUS MEDICAL INC

For the period ended Dec 31, 2025. Filed Feb 24, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 24, 2026

GMED$76.37+7.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

	December 31,	December 31,
(In thousands, except share and per share values)	2025	2024
ASSETS
Current assets:
Cash and cash equivalents	$526,156	$784,438
Short-term marketable securities	31,087	105,619
Accounts receivable, net of allowances of $33,434 and $15,505, respectively	678,938	557,697
Inventories	759,277	659,233
Prepaid expenses and other current assets	65,426	49,640
Income taxes receivable	64,727	20,633
Total current assets	2,125,611	2,177,260
Property and equipment, net	564,452	561,909
Operating lease right of use assets	63,786	49,647
Long-term marketable securities	71,819	66,134
Intangible assets, net	745,064	795,117
Goodwill	1,435,033	1,432,387
Other assets	78,781	75,096
Deferred income taxes	218,215	94,200
Total assets	$5,302,761	$5,251,750
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable	$98,852	$75,118
Accrued expenses	333,586	260,591
Operating lease liabilities	14,738	10,249
Income taxes payable	4,155	10,725
Senior convertible notes	—	443,351
Business acquisition liabilities	19,513	33,739
Deferred revenue	27,655	22,140
Total current liabilities	498,499	855,913
Business acquisition liabilities, net of current portion	81,995	89,496
Operating lease liabilities	103,918	83,588
Deferred income taxes and other tax liabilities	23,756	23,889
Other liabilities	21,343	21,531
Total liabilities	729,511	1,074,417
Commitments and contingencies (Note 15)
Equity:
Class A common stock; $0.001 par value. Authorized 500,000,000 shares; issued and outstanding 112,625,126 and 114,990,219 shares at December 31, 2025 and December 31, 2024, respectively	113	115
Class B common stock; $0.001 par value. Authorized 275,000,000 shares; issued and outstanding 22,430,097 and 22,430,097 shares at December 31, 2025 and December 31, 2024, respectively	22	22
Additional paid-in capital	3,169,812	3,031,244
Accumulated other comprehensive income/(loss)	15,346	(6,861)
Retained earnings	1,387,957	1,152,813
Total equity	4,573,250	4,177,333
Total liabilities and equity	$5,302,761	$5,251,750

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.